[Cholinesterase inhibitor].
Ueki
A
A
Department of Neuropsychiatry, Hyogo College of Medicine.
Miyoshi
K
K
D000109:Acetylcholine / Q000378:metabolism; D000544:Alzheimer Disease / Q000188:drug therapy / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004195:Disease Models, Animal; D006801:Humans; D007859:Learning Disabilities / Q000188:drug therapy / Q000378:metabolism; D008568:Memory / Q000187:drug effects; D009474:Neurons / Q000502:physiology; D010830:Physostigmine / Q000627:therapeutic use; D012601:Scopolamine / Q000494:pharmacology; D013619:Tacrine / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D013619:Tacrine; D010830:Physostigmine; D012601:Scopolamine; D000109:Acetylcholine